<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>259199</rcn>
  <id>190109979</id>
  <acronym>ROUTINE</acronym>
  <teaser>Cancer is the second leading cause of death worldwide, accounting for 10M deaths in 2020. Although 7 Immune Checkpoint Inhibitors (ICI) are approved for different cancer indications and have represented a true breakthrough, only 10-50% of advanced cancer patients respond to...</teaser>
  <objective>Cancer is the second leading cause of death worldwide, accounting for 10M deaths in 2020. Although 7 Immune Checkpoint Inhibitors (ICI) are approved for different cancer indications and have represented a true breakthrough, only 10-50% of advanced cancer patients respond to the treatment. This unpredictability of results, together with 15-60% severe toxicity rates and high prices are restricting the impact potential of ICIs. Predicting ICI response is critical for fully realizing their potential in treating early-stage tumours and enhancing ICI treatment regimens.

PamGenes IOpener is a ground-breaking in vitro diagnostics testing platform for ICI response prediction. Made possible by PamGenes proprietary microarray-based kinase activity profiling of host immune cells, it can predict a patients response before ICI therapy is started from a simple blood draw. The IOpener aims to revolutionize the precision-medicine sector, enabling the widespread use of ICIs at any cancer stage.</objective>
  <title>canceR agnOstic immUnoTherapy predIctioN blood-tEst</title>
  <keywords>In vitro diagnostic testing platform,Immunotherapy response prediction tool,Kinase activity profiling,Multi-omics,Immune checkpoint inhibitors</keywords>
  <totalCost>3669631.25</totalCost>
  <ecMaxContribution>2500000</ecMaxContribution>
  <startDate>2023-08-01</startDate>
  <endDate>2025-07-31</endDate>
  <ecSignatureDate>2023-11-20</ecSignatureDate>
  <duration>24</duration>
  <status>SIGNED</status>
  <identifiers>
    <grantDoi>10.3030/190109979</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2024-12-31 09:30:22</sourceUpdateDate>
  <contentCreationDate readOnly="true">2024-01-08 20:35:53</contentCreationDate>
  <contentUpdateDate>2024-01-08 20:35:38</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-10-06 12:10:43</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>455823</rcn>
        <id>455823-predicting-patient-response-to-immune-checkpoint-inhibitors</id>
        <title>Predicting patient response to immune checkpoint inhibitors</title>
        <contentUpdateDate>2025-04-17 11:22:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="applicationDomain" type="isApplicableIn">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/health</code>
              <title>Health</title>
              <displayCode readOnly="true">/Health</displayCode>
            </category>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode readOnly="true">/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55873</rcn>
        <title>HORIZON-EIC-2023-ACCELERATOR-01</title>
        <identifier>HORIZON-EIC-2023-ACCELERATOR-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55873</rcn>
        <title>HORIZON-EIC-2023-ACCELERATOR-01</title>
        <identifier>HORIZON-EIC-2023-ACCELERATOR-01</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="2500000" terminated="false" sme="true" netEcContribution="2500000" totalCost="3669631.25" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1933093</rcn>
        <id>986392710</id>
        <vatNumber>NL809175939B01</vatNumber>
        <legalName>PAMGENE INTERNATIONAL BV</legalName>
        <shortName>PAMGENE INT  BV</shortName>
        <address>
          <street>WOLVENHOEK  10</street>
          <city>S HERTOGENBOSCH</city>
          <postalCode>5211 HH</postalCode>
          <country>NL</country>
          <postBox>1345</postBox>
          <url>http://www.pamgene.com</url>
          <geolocation>52.0563631,4.400845863918293</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <rcn>1471688</rcn>
              <nutsCode>NL416</nutsCode>
            </region>
            <region type="relatedRegion">
              <name>Netherlands</name>
              <rcn>391547432</rcn>
              <nutsCode>NL</nutsCode>
              <euCode>NL</euCode>
              <isoCode>NL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>707290</rcn>
        <id>HORIZON_HORIZON-EIC-2023-ACCELERATORCHALLENGES-01</id>
        <code>HORIZON-EIC-2023-ACCELERATORCHALLENGES-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>EIC Accelerator Challenge: Novel biomarker-based assays to guide personalised cancer treatment</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237608</rcn>
        <id>190109979_9D1EE0C477A7C9736C83E6A57CE07C45_IPRHORIZON</id>
        <title>METHODS FOR PREDICTING THE RESPONSE OF A PATIENT TO TREATMENT WITH A PD-1 OR PD-L1 IMMUNE CHECKPOINT INHIBITOR</title>
        <details>
          <iprAwarded/>
          <iprDate>2021-09-03</iprDate>
          <iprNumber>21074319</iprNumber>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode readOnly="true">/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1933093</rcn>
              <id>986392710</id>
              <vatNumber>NL809175939B01</vatNumber>
              <legalName>PAMGENE INTERNATIONAL BV</legalName>
              <shortName>PAMGENE INT  BV</shortName>
              <address>
                <street>WOLVENHOEK  10</street>
                <city>S HERTOGENBOSCH</city>
                <postalCode>5211 HH</postalCode>
                <country>NL</country>
                <postBox>1345</postBox>
                <url>http://www.pamgene.com</url>
                <geolocation>52.0563631,4.400845863918293</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <rcn>1471688</rcn>
                    <nutsCode>NL416</nutsCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Netherlands</name>
                    <rcn>391547432</rcn>
                    <nutsCode>NL</nutsCode>
                    <euCode>NL</euCode>
                    <isoCode>NL</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237605</rcn>
        <id>190109979_3AD9A177087A1EA64FF824B074D2A292_IPRHORIZON</id>
        <title>IOpener trademark</title>
        <details>
          <iprAwarded>Madrid (WIPO)</iprAwarded>
          <iprDate>2019-11-22</iprDate>
          <iprNumber>1406476</iprNumber>
          <iprPrefix>BX</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/TRADEMARK</code>
              <title>Trademark</title>
              <displayCode readOnly="true">/Trademark</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1933093</rcn>
              <id>986392710</id>
              <vatNumber>NL809175939B01</vatNumber>
              <legalName>PAMGENE INTERNATIONAL BV</legalName>
              <shortName>PAMGENE INT  BV</shortName>
              <address>
                <street>WOLVENHOEK  10</street>
                <city>S HERTOGENBOSCH</city>
                <postalCode>5211 HH</postalCode>
                <country>NL</country>
                <postBox>1345</postBox>
                <url>http://www.pamgene.com</url>
                <geolocation>52.0563631,4.400845863918293</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <rcn>1471688</rcn>
                    <nutsCode>NL416</nutsCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Netherlands</name>
                    <rcn>391547432</rcn>
                    <nutsCode>NL</nutsCode>
                    <euCode>NL</euCode>
                    <isoCode>NL</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237603</rcn>
        <id>190109979_1C16EA61163740C781F0CBDEFF7AA07F_IPRHORIZON</id>
        <title>METHOD FOR PREDICTING THE RESPONSE OF MELANOMA PATIENTS TO A MEDICAMENT</title>
        <details>
          <iprAwarded/>
          <iprDate>2017-03-31</iprDate>
          <iprNumber>17057643</iprNumber>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode readOnly="true">/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1933093</rcn>
              <id>986392710</id>
              <vatNumber>NL809175939B01</vatNumber>
              <legalName>PAMGENE INTERNATIONAL BV</legalName>
              <shortName>PAMGENE INT  BV</shortName>
              <address>
                <street>WOLVENHOEK  10</street>
                <city>S HERTOGENBOSCH</city>
                <postalCode>5211 HH</postalCode>
                <country>NL</country>
                <postBox>1345</postBox>
                <url>http://www.pamgene.com</url>
                <geolocation>52.0563631,4.400845863918293</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <rcn>1471688</rcn>
                    <nutsCode>NL416</nutsCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Netherlands</name>
                    <rcn>391547432</rcn>
                    <nutsCode>NL</nutsCode>
                    <euCode>NL</euCode>
                    <isoCode>NL</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1150927</rcn>
        <id>190109979_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - ROUTINE (canceR agnOstic immUnoTherapy predIctioN blood-tEst)</title>
        <teaser>Cancer is the second leading cause of death worldwide, accounting for 10M deaths in 2020. Although a new class of cancer medications (Immune Checkpoint Inhibitors (ICI)) are approved for different cancer indications and have represented a true breakthrough, only 10-50% of...</teaser>
        <description>periodic</description>
        <sourceUpdateDate>2024-08-17 03:31:50</sourceUpdateDate>
        <contentUpdateDate>2024-08-20 17:18:12</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode readOnly="true">/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1367112</rcn>
        <id>190109979_233636_PUBLIHORIZON</id>
        <title>Predicting response to immunotherapy in lung cancer: an early HTA of predictive tests</title>
        <details>
          <authors>Tim Govers, Evelien van Well, Rik De Wijn, Michel van den Heuvel</authors>
          <journalNumber>41</journalNumber>
          <journalTitle>International Journal of Technology Assessment in Health Care</journalTitle>
          <publishedPages/>
          <publishedYear>2025</publishedYear>
          <publisher>Cambridge University Press (CUP)</publisher>
        </details>
        <identifiers>
          <doi>10.1017/S0266462325100317</doi>
          <issn>0266-4623</issn>
        </identifiers>
        <sourceUpdateDate>2025-09-29 12:39:41</sourceUpdateDate>
        <contentUpdateDate>2025-10-06 12:10:42</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode readOnly="true">/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237609</rcn>
        <id>190109979_6A5B1CBBDA9EBAC96F88480C641FD3A7_IPRHORIZON</id>
        <title>KINASE ACTIVITY SIGNATURES FOR PREDICTING THE RESPONSE OF NON-SMALL-CELL LUNG CARCINOMA PATIENTS TO A PD-1 OR PD-L1 IMMUNE CHECKPOINT INHIBITOR</title>
        <details>
          <iprAwarded/>
          <iprDate>2020-09-04</iprDate>
          <iprNumber>20074703</iprNumber>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode readOnly="true">/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1933093</rcn>
              <id>986392710</id>
              <vatNumber>NL809175939B01</vatNumber>
              <legalName>PAMGENE INTERNATIONAL BV</legalName>
              <shortName>PAMGENE INT  BV</shortName>
              <address>
                <street>WOLVENHOEK  10</street>
                <city>S HERTOGENBOSCH</city>
                <postalCode>5211 HH</postalCode>
                <country>NL</country>
                <postBox>1345</postBox>
                <url>http://www.pamgene.com</url>
                <geolocation>52.0563631,4.400845863918293</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <rcn>1471688</rcn>
                    <nutsCode>NL416</nutsCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Netherlands</name>
                    <rcn>391547432</rcn>
                    <nutsCode>NL</nutsCode>
                    <euCode>NL</euCode>
                    <isoCode>NL</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237596</rcn>
        <id>190109979_A7D10D021E98CED56780785FE60B7E00_IPRHORIZON</id>
        <title>MODIFIED TYROSINE AMINO ACIDS, PEPTIDES CONTAINING THEM, AND THEIR USE FOR DETECTING HYDROLASE ENZYME ACTIVITY</title>
        <details>
          <iprAwarded>EP</iprAwarded>
          <iprDate>2012-05-18</iprDate>
          <iprNumber>12059293</iprNumber>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode readOnly="true">/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1933093</rcn>
              <id>986392710</id>
              <vatNumber>NL809175939B01</vatNumber>
              <legalName>PAMGENE INTERNATIONAL BV</legalName>
              <shortName>PAMGENE INT  BV</shortName>
              <address>
                <street>WOLVENHOEK  10</street>
                <city>S HERTOGENBOSCH</city>
                <postalCode>5211 HH</postalCode>
                <country>NL</country>
                <postBox>1345</postBox>
                <url>http://www.pamgene.com</url>
                <geolocation>52.0563631,4.400845863918293</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <rcn>1471688</rcn>
                    <nutsCode>NL416</nutsCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Netherlands</name>
                    <rcn>391547432</rcn>
                    <nutsCode>NL</nutsCode>
                    <euCode>NL</euCode>
                    <isoCode>NL</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237607</rcn>
        <id>190109979_471C0A9ED1869C3B3F9284E91E0CC0C3_IPRHORIZON</id>
        <title>METHOD FOR PREDICTING THE RESPONSE OF MELANOMA PATIENTS TO TARGETED PHARMACOTHERAPY</title>
        <details>
          <iprAwarded>EP</iprAwarded>
          <iprDate>2016-05-20</iprDate>
          <iprNumber>16061361</iprNumber>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode readOnly="true">/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1933093</rcn>
              <id>986392710</id>
              <vatNumber>NL809175939B01</vatNumber>
              <legalName>PAMGENE INTERNATIONAL BV</legalName>
              <shortName>PAMGENE INT  BV</shortName>
              <address>
                <street>WOLVENHOEK  10</street>
                <city>S HERTOGENBOSCH</city>
                <postalCode>5211 HH</postalCode>
                <country>NL</country>
                <postBox>1345</postBox>
                <url>http://www.pamgene.com</url>
                <geolocation>52.0563631,4.400845863918293</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <rcn>1471688</rcn>
                    <nutsCode>NL416</nutsCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Netherlands</name>
                    <rcn>391547432</rcn>
                    <nutsCode>NL</nutsCode>
                    <euCode>NL</euCode>
                    <isoCode>NL</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237598</rcn>
        <id>190109979_A2CEE133A4DD24EFEC5FECAF76D183FF_IPRHORIZON</id>
        <title>METHOD FOR PREDICTING THE RESPONSE OF NON-SMALL CELL LUNG CANCER PATIENTS TO TARGETED PHARMACOTHERAPY</title>
        <details>
          <iprAwarded>EP</iprAwarded>
          <iprDate>2010-04-12</iprDate>
          <iprNumber>10054772</iprNumber>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode readOnly="true">/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1933093</rcn>
              <id>986392710</id>
              <vatNumber>NL809175939B01</vatNumber>
              <legalName>PAMGENE INTERNATIONAL BV</legalName>
              <shortName>PAMGENE INT  BV</shortName>
              <address>
                <street>WOLVENHOEK  10</street>
                <city>S HERTOGENBOSCH</city>
                <postalCode>5211 HH</postalCode>
                <country>NL</country>
                <postBox>1345</postBox>
                <url>http://www.pamgene.com</url>
                <geolocation>52.0563631,4.400845863918293</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <rcn>1471688</rcn>
                    <nutsCode>NL416</nutsCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Netherlands</name>
                    <rcn>391547432</rcn>
                    <nutsCode>NL</nutsCode>
                    <euCode>NL</euCode>
                    <isoCode>NL</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237593</rcn>
        <id>190109979_943ED4B95B44B2325E9C49E73F73D4DD_IPRHORIZON</id>
        <title>METHOD FOR PREDICTING THE RESPONSE OF NON-SMALL-CELL LUNG CARCINOMA PATIENTS TO A MEDICAMENT</title>
        <details>
          <iprAwarded>EP</iprAwarded>
          <iprDate>2018-08-09</iprDate>
          <iprNumber>18071569</iprNumber>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode readOnly="true">/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1933093</rcn>
              <id>986392710</id>
              <vatNumber>NL809175939B01</vatNumber>
              <legalName>PAMGENE INTERNATIONAL BV</legalName>
              <shortName>PAMGENE INT  BV</shortName>
              <address>
                <street>WOLVENHOEK  10</street>
                <city>S HERTOGENBOSCH</city>
                <postalCode>5211 HH</postalCode>
                <country>NL</country>
                <postBox>1345</postBox>
                <url>http://www.pamgene.com</url>
                <geolocation>52.0563631,4.400845863918293</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <rcn>1471688</rcn>
                    <nutsCode>NL416</nutsCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Netherlands</name>
                    <rcn>391547432</rcn>
                    <nutsCode>NL</nutsCode>
                    <euCode>NL</euCode>
                    <isoCode>NL</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode readOnly="true">/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/155/643</code>
        <title>immunotherapy</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/immunology/immunotherapy</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-EIC-ACC-BF</code>
        <title>HORIZON EIC Accelerator Blended Finance</title>
        <description>HORIZON EIC Accelerator Blended Finance</description>
        <displayCode readOnly="true">/HORIZON EIC Accelerator Blended Finance</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
